Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. - Galsky MD; Daneshmand S; Izadmehr S; Gonzalez-Kozlova E; Chan KG; Lewis S; Achkar BE; Dorff TB; Cetnar JP; Neil BO; D'Souza A; Mamtani R; et al. (Nature medicine, 2024)